KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) EBIT (2016 - 2026)

Clorox has reported EBIT over the past 18 years, most recently at $466.0 million for Q1 2026.

  • For Q1 2026, EBIT rose 3.56% year-over-year to $466.0 million; the TTM value through Mar 2026 reached $1.8 billion, down 8.75%, while the annual FY2025 figure was $2.0 billion, 12.14% up from the prior year.
  • EBIT for Q1 2026 was $466.0 million at Clorox, up from $431.0 million in the prior quarter.
  • Over five years, EBIT peaked at $596.0 million in Q2 2025 and troughed at $227.0 million in Q3 2023.
  • A 5-year average of $427.8 million and a median of $433.0 million in 2024 define the central range for EBIT.
  • Biggest five-year swings in EBIT: soared 118.06% in 2024 and later tumbled 41.21% in 2025.
  • Year by year, EBIT stood at $305.0 million in 2022, then surged by 67.87% to $512.0 million in 2023, then dropped by 16.6% to $427.0 million in 2024, then increased by 0.94% to $431.0 million in 2025, then grew by 8.12% to $466.0 million in 2026.
  • Business Quant data shows EBIT for CLX at $466.0 million in Q1 2026, $431.0 million in Q4 2025, and $291.0 million in Q3 2025.